Science · Open for opinions
Which research area of the CRS-35 microgravity neurodegeneration study will receive the first publicly released scientific result?
The CRS-35 mission includes a pioneering study using cells from ethnically diverse populations to investigate how… 79 opinions, 39% Parkinson's Disease
- Parkinson's Disease — 39%
- Primary Progressive Multiple Sclerosis — 15%
- Alzheimer's Disease — 20%
- Joint outcome / no distinction by disease — 25%
Deadline: April 14, 2027 at 12:00 AM UTC · 79 opinions
Resolution rules
The CRS-35 mission includes a pioneering study using cells from ethnically diverse populations to investigate how neurodegenerative disease biology and therapeutic responses vary in the microgravity environment on the ISS.
Source: www.axiomspace.com
Frequently asked questions about this event
How is this event resolved?
Resolução pelo primeiro comunicado oficial, artigo ou preprint publicado pela Axiom Space, NSCF ou Saudi Space Agency que apresente dados primários da missão CRS-35 identificando explicitamente a doença estudada. Fonte: axiomspace.com, stemcell.org ou publicação científica indexada.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now Parkinson's Disease has 39% of the votes: an opinion on it that turns out right earns about 61 points, a wrong one costs about 39.